IL319577A - הרכבים משולבים אימונוגניים אקסוזומליים ושיטות - Google Patents

הרכבים משולבים אימונוגניים אקסוזומליים ושיטות

Info

Publication number
IL319577A
IL319577A IL319577A IL31957725A IL319577A IL 319577 A IL319577 A IL 319577A IL 319577 A IL319577 A IL 319577A IL 31957725 A IL31957725 A IL 31957725A IL 319577 A IL319577 A IL 319577A
Authority
IL
Israel
Prior art keywords
exosomal
methods
combination
immunogenic compositions
immunogenic
Prior art date
Application number
IL319577A
Other languages
English (en)
Original Assignee
Capricor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capricor Inc filed Critical Capricor Inc
Publication of IL319577A publication Critical patent/IL319577A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL319577A 2022-09-30 2023-09-28 הרכבים משולבים אימונוגניים אקסוזומליים ושיטות IL319577A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263412226P 2022-09-30 2022-09-30
US202363455902P 2023-03-30 2023-03-30
PCT/US2023/075343 WO2024073552A2 (en) 2022-09-30 2023-09-28 Combination exosomal immunogenic compositions and methods

Publications (1)

Publication Number Publication Date
IL319577A true IL319577A (he) 2025-05-01

Family

ID=90479279

Family Applications (1)

Application Number Title Priority Date Filing Date
IL319577A IL319577A (he) 2022-09-30 2023-09-28 הרכבים משולבים אימונוגניים אקסוזומליים ושיטות

Country Status (7)

Country Link
EP (1) EP4593803A2 (he)
JP (1) JP2025532934A (he)
CN (1) CN120344260A (he)
AU (1) AU2023353862A1 (he)
CA (1) CA3266047A1 (he)
IL (1) IL319577A (he)
WO (1) WO2024073552A2 (he)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2297200A1 (en) * 2008-04-09 2011-03-23 Technion Research & Development Foundation Ltd. Anti influenza antibodies and uses thereof
US9550811B2 (en) * 2010-12-02 2017-01-24 Bionor Immuno As Peptide scaffold design
CA2980819C (en) * 2015-03-05 2024-03-05 Peter Und Traudl Engelhorn-Stiftung Zur Forderung Der Lebenswissenschaften System for the presentation of peptides on the cell surface
AU2021236391A1 (en) * 2020-03-13 2022-09-29 Capricor, Inc. Exosomal nucleic acid vaccine modularly configured to harness multiple antigen presentation mechanisms
US12077758B2 (en) * 2020-05-28 2024-09-03 University Of Massachusetts Oligonucleotides for SARS-CoV-2 modulation
US11130787B2 (en) * 2020-06-11 2021-09-28 MBF Therapeutics, Inc. Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods
CN116940589A (zh) * 2021-01-29 2023-10-24 上海锦斯生物技术有限公司 重组sars-cov-2疫苗

Also Published As

Publication number Publication date
CA3266047A1 (en) 2024-04-04
AU2023353862A1 (en) 2025-05-15
WO2024073552A2 (en) 2024-04-04
JP2025532934A (ja) 2025-10-03
EP4593803A2 (en) 2025-08-06
CN120344260A (zh) 2025-07-18
WO2024073552A3 (en) 2024-08-02

Similar Documents

Publication Publication Date Title
PL4208045T3 (pl) Kompozycje i sposoby
GB202111040D0 (en) Compositions and methods
GB202108585D0 (en) Methods and compositions
GB202416789D0 (en) SARS-COV-2 immunogenic compositions
GB202004677D0 (en) Methods and compositions
IL319577A (he) הרכבים משולבים אימונוגניים אקסוזומליים ושיטות
GB202316199D0 (en) Compositions and methods and uses thereto
IL304824A (he) שיטות ותכשירי פוספרופופול
GB202116554D0 (en) Methods and compositions
GB202110091D0 (en) Methods and compositions
GB202203250D0 (en) Immunogenic compositions
CA3265594A1 (en) IMMUNOGENEOUS COMPOSITIONS AND METHODS AGAINST SARS-CoV-2
IL321428A (he) תרכובות ושיטות
GB202316109D0 (en) Methods and compositions
GB202316106D0 (en) Methods and compositions
GB202311858D0 (en) Methods and compositions
GB202308901D0 (en) Methods and compositions
GB202307563D0 (en) Methods and compositions
GB202305427D0 (en) Methods and compositions
GB202304240D0 (en) Compositions and methods
IL315882A (he) נוגדנים כנגד ilt4, תכשירים ושיטות
GB202219851D0 (en) Compositions and methods
GB202209588D0 (en) Methods and compositions
GB202209115D0 (en) Compositions and methods
GB202206268D0 (en) Compositions and methods